Share
Sponsored News Content
JOIN OUR FREE TODAY
Join Free
Investorideas.com (www.investorideas.com newswire) a leading investment platform for retail investors reports breaking
Medical Tech Stock news for
Aethlon Medical, Inc.
(Nasdaq: AEMD), a medical therapeutic company focused on developing products to
treat cancer and life-threatening infectious diseases.
Aethlon Medical, Inc. (Nasdaq: AEMD) is trading at 2.9651 +0.5151
(+21.02%) as of this report on volume of over 11.8 Million shares.
A serious Bundibugyo Ebola outbreak in central Africa is escalating
quickly, prompting a global health emergency declaration and
heightened response efforts. This has boosted interest in companies
like Aethlon Medical, whose virus-filtering technology could play a
role in treatment, lifting its stock price amid the news.
Other Ebola stocks are seeing big gains as headlines this morning
say the outbreak is escalating faster than the response.
“SNGX Stock More Than Doubles In Pre-Market, Eyes $1 Breakout For
First Time In A Month – Ebola Vaccine Optimism Fuels Retail
Frenzy”
https://stocktwits.com/news-articles/markets/equity/why-is-sngx-stock-up-today-soligenix-ebola-vaccine/cZggefKReAA
These big stock moves are high-risk and volatile and will change
with the headlines.
Aethlon Medical, Inc. (NASDAQ: AEMD) recently announced that it is
actively monitoring developments related to the current Bundibugyo
Ebola virus outbreak in Democratic Republic of the Congo and Uganda
and remains prepared to engage with global healthcare and regulatory
authorities regarding the potential investigational use of its
Hemopurifier(R) technology.
Aethlon’s Hemopurifier is an investigational medical device designed
to remove enveloped viruses and tumor-derived EVs from circulation.
During the 2014 Ebola (Zaire strain) outbreak, the Hemopurifier was
successfully administered to a critically ill Ugandan physician
treated at Frankfurt University Hospital under emergency-use
circumstances.
At the time Hemopurifier therapy was initiated, the physician was
unconscious and suffering from multiple organ failure requiring
mechanical ventilation, vasopressor support and continuous dialysis.
Following a single 6.5-hour Hemopurifier treatment, the patient’s
viral load reportedly declined from approximately 400,000 Ebola
virus copies per milliliter of blood to approximately 1,000 copies
per milliliter of blood. The Ebola virus subsequently became
undetectable five days following treatment. Testing performed after
this treatment indicated that the Hemopurifier captured Ebola virus
during therapy; quantitative estimates reported at the time, were
approximately 242 million virions. The patient ultimately made
recovered and returned home to Uganda.
Full news
https://www.investorideas.com/CO/AEMD/news/2026/05211-aethlon-medical-aemd-ebola-outbreak-hemopurifier.asp
Aethlon Medical Inc. (Nasdaq: AEMD) is a featured biotech stock on
Investorideas.com
More info on AEMD at Investorideas.com Visit:
https://www.investorideas.com/CO/AEMD/
Get News Alerts on Aethlon Medical
Research biotech stocks at Investorideas.com
https://www.investorideas.com/Companies/RenewableEnergy/stock_list.asp
About Investorideas.com – Where You Find The Best Investing Ideas
Investorideas.com
is a trusted platform for retail investors, serving as a hub for
innovative investing ideas for over 25 years. Known for its pioneering
coverage of sectors like mining, cleantech, defense, and water stocks,
the company and its executives have been featured in high-profile
media outlets for its expertise. With a mission to empower investors,
the company provides breaking news, sector-focused articles, podcasts,
and exclusive interviews with leading experts.
Advertising agencies – Learn more about digital advertising and
guest posts at Investorideas
https://www.investorideas.com/Advertise/
Follow & Contact
Follow us on X: @investorideas, @stocknewsbites
Facebook: Investorideas Facebook
YouTube: Investorideas YouTube
Investors stay ahead by signing up for free stock news alerts at
Investorideas.com
https://www.investorideas.com/Resources/Newsletter.asp
Join our free Telegram community
https://t.me/+o8DxSAgeNCk2ZGVh
Contact us for more info
Call 800 665 0411
Disclaimer/Disclosure: Aethlon Medical, Inc.
(AEMD) is a paid featured medical tech stock on Investorideas. Our site
does not make recommendations for purchases or sale of stocks, services
or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing
involves risk and possible losses. This site is currently compensated
for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the
news was not compensated for and was published for the sole interest of
our readers and followers. Contact management and IR of each company
directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp
